Gapping down
In reaction to disappointing earnings/guidance: GSI -8.8%, WCRX -7.1%, RJET -6.3%, CYTR -5.8%, ANSW -1.7%, KWK -0.8%, FTR -0.6%
Select energy and materials showing weakness: BHP -1.9%, FRO -1.7%, ABB -1.7%, BP -1.6%, PBR -1.2%
Other news: INVE -22.7% (still checking), SIGA -18.6% (unfavorable ruling from SBA), IRE -14.7% (continued selling overseas), PIP -12.8% (still checking), CADX -4.8% (offering to sell $85 million worth of shares of its common stock), NOK -2.3% (hearing European downgrade), BUD -1.9% (still checking), RDS.A -1.7% (reduces its interest in Woodside), EXM -1.4% (COO to leave)
Analyst comments: SWKS -6.2% (downgraded to Outperform at Raymond James), ALU -4.3% (downgraded to Underperform at Bernstein), CLWR -3.3% (downgraded to Hold at Kaufman Bros ), DISH -3.3% (downgraded to Neutral at UBS), SWY -1.7% (downgraded to Sell at UBS), TI -1.7% (downgraded to Neutral at Credit Suisse), SCCO -1.4% (downgraded to Sell at UBS), AMRS -1.2% (initiated with Neutral at Goldman), RFMD -1.1% (downgraded to Outperform at Raymond James), LOW -0.9% (downgraded to Market Perform at Raymond James), HD -0.8% (downgraded to Market Perform at Raymond James), AA -0.7% (downgraded to Neutal at Davenport)
Gapping up
In reaction to strong earnings/guidance: HIHO +25.7%, SOLR +11.7%, ASTM +5.7%, ATPG +3.8%, MDVN +2.4%, FTR +1.4%, KH +1.3%, XNPT +1.1%, (also Co and GSK respond to FDA on Horizant for RLS), BPL +0.8%
Select solar names moving with SOLR: STP +1.6%, LDK +1.1%, JKS +0.9%
Other news: IDT +18.7% (announces strategic initiatives), SBAY +16.2% (still checking), ATHX +12.3% (FDA authorization of Phase II clinical trial for inflammatory bowel disease with PFE), SYKE +7.6% (still checking), CTV +6.6% (CNBC reported that TPG is considering whether to submit offer for co to top Carlyle bid), XNPT +6.1% (Co and GSK respond to FDA on Horizant for RLS), MGM +2.8% Cramer comments RES +2.6% (ex-dividend), EGHT +2.3% (still checking), DELL +2.3% (rumor going private), MRVL +0.9% (unveil its quad-core processing ARMADA XP)
Analyst comments: DLM +4.0% (initiated with Neutral at Suntrust ), DEG +1.8% (upgraded to Overweight at HSBC), SVNT +1.4% (upgraded to Buy at Soleil, light volume), INTC +1.0% (upgraded to Buy at UBS)